Stroke

[Bevacizumab for the treatment of cerebral radionecrosis].

Abstract: Bevacizumab is a monoclonal antibody, which neutralizes the effect of vascular endothelium growth factor (VEGF) allowing regression of tumour vessels and a decrease in the permeability of the blood-brain barrier. Already used in oncology as adjuvant...

Archives

Categories